Penalty Amount
$1,050,000
New York and a coalition of 47 other attorneys general secured settlements with Ascend Laboratories and Mayne Pharma over an alleged scheme to inflate generic drug prices and reduce competition. Mayne agreed to pay $650,000 and Ascend $400,000, with settlement funds distributed to impacted consumers and the companies agreeing to internal antitrust reforms.
Mayne will pay $650,000 and Ascend will pay $400,000, with funds distributed to impacted consumers across coalition states. Each company also agreed to internal reforms, including annual antitrust compliance training.
This action concerns antitrust conduct rather than a privacy violation, so privacy-specific clauses are not implicated by the release. In vendor, distributor, and customer agreements—especially those involving generic pharmaceuticals, pricing, supply, or bids—review clauses requiring independent pricing and bidding decisions, prohibiting coordination or exchange of competitively sensitive information, and requiring compliance with antitrust laws. Consider adding or strengthening antitrust training, certification, audit, and escalation obligations; employee agreements and policies governing competitor contact may also warrant review.
Entity
Ascend Laboratories and Mayne Pharma
Industry
HealthcareOfficial Press Release
https://ag.ny.gov/press-release/2026/attorney-general-james-secures-over-1-million-ascend-laboratories-and-mayne
connecticut et al v aurobindo pharma usa inc et al memorandu
https://ag.ny.gov/sites/default/files/settlements-agreements/connecticut-et-al-v-aurobindo-pharma-usa-inc-et-al-memorandum-2026.pdf
New York Attorney General Enforcement Page
https://ag.ny.gov/press-releases
"October 8, 2026"
"from Ascend Laboratories (Ascend) and Mayne Pharma (Mayne)"
"Mayne will pay $650,000 and Ascend will pay $400,000."
"compliance with antitrust laws"
"to artificially inflate generic drug prices and reduce competition"
New York Attorney General Letitia James joined a 15-state coalition in suing HHS Secretary Robert F. Kennedy, Jr., challenging changes that removed seven vaccines from the CDC’s list of vaccinations recommended for every child. The states allege the changes and ACIP appointments violated the Administrative Procedure Act and ask the court to invalidate them; the release reports no penalty or court-ordered remedy.
New York Attorney General Letitia James joined a coalition lawsuit challenging NHTSA’s rollback of federal fuel economy standards. The coalition alleges that the final rule violates federal law and asks the court to strike it down; the press release describes no privacy violations or monetary penalty.
$400.0M
New York Attorney General Letitia James and a coalition of 47 other attorneys general secured a $400 million settlement with Sandoz Inc. and Fougera Pharmaceuticals Inc. over an alleged scheme to coordinate generic drug prices and reduce competition. The settlement provides for consumer compensation and requires Sandoz to implement antitrust compliance reforms, including annual staff training and a Chief Compliance Officer.
New York Attorney General Letitia James joined eight other attorneys general in issuing a statement criticizing a DOJ judicial misconduct complaint against nearly all federal district court judges in Minnesota. The release concerns judicial independence, not a privacy enforcement action; it announces no penalty or privacy-related remedy.
$5.9M
New York Attorney General Letitia James sued Evolutions Festival LLC and 845 Vibrations LLC over the cancellation of the 2025 festival and their failure to refund ticket holders and vendors. The state alleges violations of laws governing advance ticket-sale funds and seeks restitution, civil penalties of $5,000 for each of 1,185 alleged violations, and an order requiring a $500,000 bond before the organizers can hold future cultural events in New York.
$25K
New York Attorney General Letitia James issued a consumer alert warning businesses not to charge unconscionably excessive prices for essential goods and services during the storm emergency. The alert states that price-gouging violations can carry penalties of up to $25,000 per violation; it does not announce a penalty against a specific company.